Tyler Jensen, SVP, Engineering and Technology Development at GenMark Diagnostics, Inc. (GNMK), sold 500 shares at $14.46 ($7K) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Scheduled sale ($7k) by SVP, Engineering and Technology Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-02-22 | $11K | — | Filing → |
| GNMK | SELL | 2021-02-16 | $220K | — | Filing → |
| GNMK | SELL | 2021-02-08 | $7K | — | Filing → |